Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Leukemia, Myeloid, Acute × Dasatinib × Clear all

Phase

Status

Sponsor Class

OTHER 14 INDUSTRY 2 OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 1 Leukemia, Myeloid, Accelerated Phase 1

Interventions

Azacitidine 3 venetoclax 2 fludarabine 2 vosaroxin 1 treosulfan 1 liposomal amphotericin B 1 defactinib 1 decitabine and cedazuridine drug combination 1 cedazuridine 1 cc-486 1 bisantrene 1 Mycophenolic Acid 1 Methotrexate 1 Idarubicin 1 Human Papillomavirus Recombinant Vaccine nonavalent 1 Filgrastim 1 Everolimus 1 Dexamethasone 1 Decitabine 1 Daunorubicin 1 Dasatinib 1 Cytarabine 1 Cyclosporine 1 Cyclophosphamide 1 Control Groups 1 Clofarabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02113319 2014-04-14

DasaCBF

University Hospital, Angers

Phase 2 Completed

Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon ⚡